The Visa and Starbucks-backed mobile payment company is set to float at a valuation at least 30% less than at its last equity round.

Johnson & Johnson has agreed to acquire Novira Therapeutics for an undisclosed sum, providing an exit to WuXi PharmaTech, an investor in its $28m series A round.

The Novartis-backed eye disease therapy developer set the range last month for an initial public offering sized at up to $65m.

Fidelity-backed biopharmaceutical company Kura floated on Nasdaq yesterday and will use proceeds to fund clinical trials.

State-owned debt management firm China Huarong Asset Management raises $2.3bn in its IPO, falling short of its $3bn target.

The classified listings website, spun out of eBay, is seeking a flotation on Chinese stock exchange National Equities Exchange and Quotations.

Vipshop-backed online fashion retailer Showroomprive floated below its range, selling individual shares at $2.25 below target.

Carnegie Mellon University spinout Blue Belt Technologies acquired by Smith & Nephew for robotics technologies.

The cardiovascular drug developer, which had raised $94m from investors including Sanofi, priced its initial public offering considerably below the range set last week.

The France-based streaming platform, backed by Access Industries and Orange, has cancelled an IPO that was expected to generate more than $330m in proceeds.